malignant tumor
Conditions
Interventions
case series:Nil
Sponsors
Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China
Eligibility
Sex/Gender
All
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: Volunteers (clinically confirmed malignant tumor patients), aged > 35, < 70 years, volunteered to participate and signed informed consent, and were willing and able to comply with the requirements of the trial protocol.
Exclusion criteria
Exclusion criteria: 1) People who has birth plan during the trial period and within 1 year after completion of the trial,or subjects and their spouses could not comply with contraceptive measures during the trial period and within 1 year after completion of the trial; 2)Female subjects during pregnancy or lactation; 3)Subjects with poor compliance or other factors deemed unfit to participate in the study by the investigator; 4)Cannot tolerate intravenous administration (such as history of fainting needles or blood); 5)Those who cannot complete PET or other imaging examinations due to special reasons, including claustrophobia and radiophobia; 6)Practitioners requiring long-term exposure to radioactive conditions; 7)Liver and renal insufficiency; 8)Allergic constitution and known multiple drug allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Organ absorbed dose; | — |
Countries
China
Contacts
Public ContactJianjun Liu
Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiaotong University
Outcome results
None listed